Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mathias

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of Medicinal Chemistry|September 6, 2011
Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary diseaseDavid S Millan, Mark E Bunnage, Jane L Burrows, et al.
Food Chemistry|March 25, 2018
Chemical, sensory, and functional properties of whey-based popsicles manufactured with watermelon juice concentrated at different temperaturesCarolina P C Martins, Marcus Vinicius S Ferreira, Erick A Esmerino, et al.
Food Research International (Ottawa, Ont.)|March 28, 2018
The xylooligosaccharide addition and sodium reduction in requeijão cremoso processed cheeseLuana L Ferrão, Marcus Vinícius S Ferreira, Rodrigo N Cavalcanti, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
Journal of Medicinal Chemistry|December 30, 2021
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1Agustin Casimiro-Garcia, Christophe Allais, Agnes Brennan, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of Medicinal Chemistry|September 6, 2011
Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary diseaseDavid S Millan, Mark E Bunnage, Jane L Burrows, et al.
Food Chemistry|March 25, 2018
Chemical, sensory, and functional properties of whey-based popsicles manufactured with watermelon juice concentrated at different temperaturesCarolina P C Martins, Marcus Vinicius S Ferreira, Erick A Esmerino, et al.
Food Research International (Ottawa, Ont.)|March 28, 2018
The xylooligosaccharide addition and sodium reduction in requeijão cremoso processed cheeseLuana L Ferrão, Marcus Vinícius S Ferreira, Rodrigo N Cavalcanti, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
Journal of Medicinal Chemistry|December 30, 2021
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1Agustin Casimiro-Garcia, Christophe Allais, Agnes Brennan, et al.
Journal of Medicinal Chemistry|May 13, 2017
Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug DesignKatherine L Lee, Catherine M Ambler, David R Anderson, et al.
Pageof 8